Alzheimer's tests under fire.
Hayden
Erika Check
EC
D017668:Age of Onset; D000544:Alzheimer Disease / Q000175:diagnosis* / Q000235:genetics*; D053302:Apolipoprotein C-I / Q000235:genetics; D001057:Apolipoproteins E / Q000235:genetics; D002986:Clinical Trials as Topic; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing / Q000941:ethics / Q000331:legislation & jurisprudence*; D023281:Genomics / Q000941:ethics / Q000331:legislation & jurisprudence; D006801:Humans; D008004:Licensure / Q000331:legislation & jurisprudence; D010597:Pharmacogenetics; D015143:Philadelphia; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000494:pharmacology
C505803:APOC1 protein, human; D053302:Apolipoprotein C-I; D001057:Apolipoproteins E; D045162:Thiazolidinediones; D000077154:Rosiglitazone